YAP1802 antibody is a specialized immunological tool targeting Yap1802, the Saccharomyces cerevisiae ortholog of human phosphatidylinositol-binding clathrin assembly protein (PICALM). This protein plays critical roles in clathrin-mediated endocytosis (CME) and amyloid-β (Aβ) oligomerization regulation, with implications for neurodegenerative diseases like Alzheimer’s (AD) . The antibody enables detection and functional analysis of Yap1802 in yeast models, providing insights into conserved molecular mechanisms relevant to human pathology.
Yap1802 regulates endocytosis through three interconnected mechanisms:
Budding yeast strains with Yap1802 K21E/K23E mutations show 40% reduced plasma membrane localization due to impaired phospholipid binding .
L203S mutants exhibit defective Snc1/2 internalization, increasing Snc2 cortical signal by 2.5-fold in mother cells .
Deletion of both Yap1801/Yap1802 disrupts Snc1 polarization, mimicking clathrin-null phenotypes .
Overexpression increases clathrin-coated pit density by 30% under glucose starvation .
Yeast expressing Yap1802 show a 60% reduction in SDS-resistant Aβ42 oligomers and restored growth on -Ade media .
AD Pathogenesis: Yap1802’s ability to suppress Aβ42 oligomerization aligns with PICALM’s identification as an AD risk gene .
Drug Discovery: Seven FDA-approved drugs (e.g., haloperidol, tamoxifen) mimic Yap1802’s anti-oligomerization effects in yeast .
Vesicle Trafficking: Restoring Yap1802 function rescues endocytic defects in C. elegans and mammalian neurons .
Structural Analysis: Cryo-EM studies of Yap1802-Snc2 complexes to refine interaction interfaces .
In Vivo Models: Testing YAP1802 antibody efficacy in murine AD models with humanized PICALM variants .
Clinical Translation: Developing small-molecule agonists mimicking Yap1802’s ANTH domain for Aβ clearance .
KEGG: sce:YGR241C
STRING: 4932.YGR241C
YAP1802 is an endocytic adaptor protein found in Saccharomyces cerevisiae (baker's yeast) that functions as a homolog to mammalian AP180. It plays a key role in clathrin-mediated endocytosis (CME), particularly in the early stages of endocytic site initiation . YAP1802 and its paralog YAP1801 are critical factors that promote polarized CME, showing strong localization to the bud cortex during yeast cell growth while remaining nearly undetectable in mother cells . This explains the observed position-dependent differences in CME initiation rates and lifetimes .
YAP1802 works cooperatively with other proteins such as Syp1 (the yeast homolog of FCHo1/2) to recruit Ede1 (the yeast homolog of EPS15) to the bud cortex, thereby initiating the early stages of CME . Additionally, YAP1802 interacts with v-SNAREs Snc1 and Snc2 (abbreviated as Snc1/2), which depend on CME for their retrieval from the plasma membrane . These v-SNAREs are the only known ones in budding yeast that facilitate the fusion of secretory vesicles with the plasma membrane . YAP1802 also directly binds anionic lipid species, suggesting a multifaceted role in membrane trafficking and cellular polarity .
YAP1802 contains an ANTH (AP180 N-terminal homology) domain that mediates its interactions with both anionic phospholipids and synaptobrevins (Snc1/2 in yeast) . Key residues within this domain include lysines 21 and 23, which are critical for lipid interaction, and leucine 203, which is important for Snc1/2 interaction .
Structural studies using Alphafold2 multimer analysis have confirmed the specific interaction between L203 in YAP1802 and M42 in Snc2, strengthening confidence in the molecular basis of this protein-protein interaction . The protein also contains NPF motifs that enable interaction with Ede1, which becomes particularly evident when both lipid and Snc1/2 binding are disrupted, as YAP1802 then shows elevated localization at the bud neck where Ede1 is concentrated .
Understanding these structural features is essential for researchers designing experiments involving YAP1802 mutations or studying its binding partners in the context of endocytosis and membrane trafficking.
The commercially available YAP1802 antibodies have the following specifications:
| Parameter | Specification |
|---|---|
| Product Type | Polyclonal Antibody |
| Raised In | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Immunogen | Recombinant Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YAP1802 protein |
| Species Reactivity | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) |
| Tested Applications | ELISA, Western Blot |
| Form | Liquid |
| Purification Method | Antigen Affinity Purified |
| Storage Buffer | 0.03% Proclin 300, 50% Glycerol, 0.01M PBS (pH 7.4) |
| Storage Conditions | -20°C or -80°C, avoid repeated freeze-thaw cycles |
| Uniprot ID | P53309 |
| Lead Time | 14-16 weeks (made-to-order) |
These antibodies are designed for research use only and not for diagnostic or therapeutic procedures .
YAP1802 antibodies have been validated primarily for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) for the detection and identification of YAP1802 in Saccharomyces cerevisiae samples . These applications allow researchers to confirm the presence and relative abundance of YAP1802 in experimental samples.
In research settings studying YAP1802 function, fluorescently tagged versions (such as YAP1802-GFP) have been instrumental in visualizing the subcellular localization and dynamics of YAP1802 during endocytosis . This approach has revealed the strongly polarized distribution of YAP1802 to daughter cells during yeast budding and has enabled the quantitative analysis of YAP1802 recruitment patterns and endocytic event lifetimes .
For interaction studies, YAP1802 antibodies could potentially be used in co-immunoprecipitation experiments to investigate protein-protein interactions between YAP1802 and its binding partners, such as Snc1/2, Syp1, or Ede1, though specific protocols for this application were not explicitly mentioned in the search results.
When designing Western blot protocols using YAP1802 antibody, researchers should consider the following methodological approach:
Sample Preparation:
Extract proteins from yeast cells using appropriate lysis buffers containing protease inhibitors
Quantify protein concentration using Bradford or BCA assay
Prepare samples in SDS-PAGE loading buffer with reducing agent
Gel Electrophoresis and Transfer:
Separate proteins using SDS-PAGE with an appropriate percentage gel based on YAP1802's molecular weight
Transfer proteins to a PVDF or nitrocellulose membrane
Antibody Incubation:
Block membrane with 5% non-fat milk or BSA in TBST
Incubate with YAP1802 antibody at an optimized dilution (typically starting at 1:1000)
Wash thoroughly with TBST
Incubate with HRP-conjugated anti-rabbit secondary antibody
Detection and Controls:
Develop using enhanced chemiluminescence (ECL) reagents
Include wild-type yeast extracts as positive control
Include yap1802Δ deletion strain extracts as negative control
Use loading controls such as anti-Pgk1 or anti-Tub1 antibodies
Analysis of YAP1802 Mutations:
This methodological approach ensures specific and reliable detection of YAP1802 in yeast samples while controlling for potential sources of error.
For optimal performance and longevity of YAP1802 antibodies, researchers should follow these storage and handling protocols:
Initial Storage:
Working Solution Preparation:
Thaw antibody on ice slowly and completely
Aliquot stock solution into smaller volumes to minimize future freeze-thaw cycles
Return unused stock to -20°C or -80°C immediately
Buffer Compatibility:
Temperature Management:
Keep antibody cold (on ice or at 4°C) during experimental procedures
Avoid exposing the antibody to room temperature for extended periods
Contamination Prevention:
Use sterile technique when handling antibody solutions
Avoid introducing bacteria or fungi that could degrade the antibody
Following these protocols will help maintain antibody activity and specificity throughout its shelf life and during experimental use.
Research has demonstrated that specific mutations in key binding domains of YAP1802 significantly impact its localization and function in clathrin-mediated endocytosis (CME) . The effects of different mutations have been systematically characterized:
| Mutation | Domain Affected | Effect on Localization | Effect on Function |
|---|---|---|---|
| K21E K23E | ANTH domain (lipid binding) | Decreased plasma membrane recruitment in daughter cells | Reduced cortical Yap1802 intensity, defects in Snc2 internalization |
| L203S | ANTH domain (Snc1/2 binding) | Decreased plasma membrane recruitment | Reduced cortical Yap1802 intensity, defects in Snc2 internalization |
| K21E K23E L203S (3x PM) | Both lipid and Snc1/2 binding | Severe recruitment defect, abnormal concentration at bud neck | Significantly shorter lifetimes at endocytic sites, severe defects in Snc2 internalization |
These mutations affect not only YAP1802 localization but also the dynamics of its cargo. In yeast expressing YAP1802 with these mutations, Snc2 shows abnormal distribution patterns on the plasma membrane, with increased cortical signal in mother cells across all mutant conditions . This suggests that the interaction between YAP1802 and both lipids and cargo (Snc1/2) is crucial for proper endocytic function.
The triple mutant (K21E K23E L203S) shows an unusual concentration at the bud neck, likely due to recruitment by Ede1 through YAP1802's NPF motifs, as Ede1 is concentrated at this location . The lifetimes of this triple mutant at endocytic sites are significantly shorter than those for the wild-type and individual mutants, consistent with strains that lack the ability to localize Ede1 properly .
These findings highlight the complex interplay between YAP1802's interactions with lipids, cargo proteins, and other endocytic factors in establishing the polarized endocytic machinery in budding yeast.
YAP1802 exhibits a direct interaction with anionic phospholipid species through its ANTH domain, specifically via lysine residues 21 and 23 . This interaction is critical for the polarized recruitment of YAP1802 to the bud cortex during yeast cell growth. The relationship between YAP1802 and anionic phospholipids has several important aspects:
Lipid Specificity: YAP1802's ANTH domain can directly bind anionic lipid species, which likely contribute to its membrane association .
Polarized Distribution: Anionic lipids, particularly phosphatidylserine, are enriched in daughter cells, creating a lipid environment that favors YAP1802 recruitment . This lipid asymmetry may contribute to the observed polarization of endocytic processes.
Functional Significance: When the interaction between YAP1802 and anionic phospholipids is disrupted through K21E K23E mutations, YAP1802 shows significantly reduced plasma membrane association in daughter cells, as evidenced by decreased cortical fluorescence intensity .
Cargo Protein Effect: The defect in lipid binding not only affects YAP1802 localization but also leads to abnormal distribution of its cargo Snc2, with increased cortical signal in mother cells . This indicates that the lipid-binding function of YAP1802 is essential for proper cargo internalization.
Coordination with Protein Binding: While both lipid binding and Snc1/2 binding independently contribute to YAP1802 localization, the most severe defects are observed when both interactions are disrupted in the triple mutant (K21E K23E L203S) . This suggests that these interactions work cooperatively to ensure proper YAP1802 function.
These findings highlight the importance of membrane lipid composition in regulating the spatial organization of endocytic machinery and suggest that anionic phospholipids serve as spatial cues for the recruitment of early endocytic factors like YAP1802.
The interaction between YAP1802 and the v-SNAREs Snc1/2 represents a critical nexus between exocytosis and endocytosis in yeast cells . This relationship has several important implications for vesicle trafficking:
Cargo Recognition: YAP1802 recognizes Snc1/2 as cargo for endocytosis through a specific interaction between leucine 203 in YAP1802's ANTH domain and methionine 42 in Snc2, as confirmed by Alphafold2 multimer analysis .
Endocytic Recycling: Snc1/2 are the only known v-SNAREs in budding yeast that facilitate the fusion of secretory vesicles with the plasma membrane . After fusion, they require clathrin-mediated endocytosis (CME) for their retrieval from the plasma membrane, a process mediated by YAP1802 .
Bidirectional Influence: The YAP1802-Snc1/2 interaction appears to be bidirectional: YAP1802 mediates Snc1/2 internalization, while Snc1/2 contributes to YAP1802 recruitment to endocytic sites. When this interaction is disrupted through the L203S mutation, YAP1802's plasma membrane recruitment is impaired .
Effect on Snc1/2 Distribution: In yeast expressing the YAP1802 L203S mutant (defective in Snc1/2 binding), Snc2 shows abnormal accumulation at the cell cortex, particularly in mother cells . This indicates that the YAP1802-Snc1/2 interaction is essential for efficient Snc2 internalization.
Coordination with Lipid Binding: While the interaction with Snc1/2 contributes to YAP1802 localization, it works cooperatively with lipid binding to ensure proper YAP1802 function. The most severe defects in both YAP1802 localization and Snc2 internalization are observed when both interactions are disrupted in the triple mutant (K21E K23E L203S) .
This complex relationship between YAP1802 and Snc1/2 illustrates how the secretory and endocytic pathways are coordinated in yeast cells, with endocytic adaptor proteins recognizing and internalizing components of the exocytic machinery to maintain proper membrane homeostasis.
When conducting immunoblotting experiments with YAP1802 antibody, researchers should include the following controls to ensure result reliability and accuracy:
Positive Control: Include wild-type yeast extracts known to express YAP1802 . This confirms that the antibody and detection system are working properly.
Negative Control: Use extracts from yap1802Δ deletion strains, which should show no band at the expected molecular weight. This confirms the specificity of the antibody for YAP1802.
Antigen Competition Control: For antibody specificity validation, perform an antigen competition assay by pre-incubating the antibody with excess purified YAP1802 protein before immunoblotting. This should greatly reduce or eliminate specific binding.
Loading Controls: Use antibodies against constitutively expressed yeast proteins such as Pgk1 (phosphoglycerate kinase) or Tub1 (α-tubulin) to ensure equal loading across lanes, especially important for quantitative comparisons.
Mutation Comparison Controls: When studying YAP1802 mutants (such as K21E K23E or L203S), include wild-type YAP1802 samples in the same blot for direct comparison . This allows accurate assessment of how mutations affect protein expression or migration.
Tag Controls: If detecting tagged versions of YAP1802 (such as YAP1802-GFP), include controls with untagged YAP1802 to verify tag effects on protein migration or expression levels .
Secondary Antibody-Only Control: Include a lane where primary antibody is omitted to identify any non-specific binding of the secondary antibody.
Molecular Weight Marker: Use a pre-stained protein ladder for accurate molecular weight determination of detected bands.
These controls collectively ensure that the observed results are specific, reproducible, and reliably attributed to YAP1802 rather than experimental artifacts or cross-reactivity.
When encountering contradictory data in YAP1802 localization studies, researchers should systematically evaluate several potential sources of variation:
Strain Background Differences: Even minor genetic variations between laboratory yeast strains can affect protein localization patterns. Verify strain genotypes and consider backcrossing strains to a common background for direct comparisons.
Cell Cycle Dependence: YAP1802 localization is strongly influenced by cell cycle stage, given its polarized distribution to daughter cells during budding . Contradictions may arise if cell populations are at different cell cycle stages. Synchronize cultures or categorize cells by bud size during analysis.
Experimental Conditions: Growth media, temperature, and growth phase can alter membrane composition and endocytic dynamics. Standardize these parameters across experiments and explicitly report them to facilitate comparison.
Tag Interference: Different fluorescent protein tags can affect protein folding, interactions, or degradation rates. Compare results with multiple tag types or positions, and validate with antibody-based detection of untagged YAP1802 .
Expression Level Variations: Overexpression can lead to mislocalization or aggregation. Compare expression levels by Western blot and optimize constructs to achieve near-endogenous expression .
Functional Redundancy: Consider redundancy with YAP1801, which shares high homology with YAP1802 and may compensate for YAP1802 defects in some conditions . Studies in yap1801Δ backgrounds may reveal YAP1802-specific functions that are masked in wild-type cells.
Imaging Parameters: Exposure time, detector gain, and image processing can create apparent differences in localization. Use consistent acquisition settings and include positive controls in each experiment.
Resolution Limitations: Different microscopy techniques provide different levels of resolution. Super-resolution approaches may reveal localization details not visible with conventional microscopy.
To resolve contradictions, consider performing epistasis experiments with related proteins (Syp1, Ede1) to establish the hierarchy of interactions . It's also possible that both contradictory observations are correct under different conditions, revealing context-dependent regulation of YAP1802.
When studying the effects of YAP1802 mutations on endocytosis, researchers should employ a comprehensive methodological approach that includes:
This comprehensive approach allows researchers to connect molecular defects in YAP1802 (disrupted lipid or cargo binding) to cellular phenotypes (altered protein localization and dynamics) and ultimately to functional consequences for endocytosis and membrane trafficking.
Several cutting-edge techniques could significantly advance our understanding of YAP1802 function in endocytosis and membrane trafficking:
Super-Resolution Microscopy:
Techniques like PALM, STORM, or lattice light-sheet microscopy could visualize YAP1802 dynamics at nanoscale resolution
These approaches could reveal details of endocytic site formation previously unobservable with conventional microscopy
Multi-color super-resolution imaging could precisely map the spatial relationships between YAP1802 and other endocytic proteins
Proximity Labeling:
Advanced Lipidomics:
Mass spectrometry-based lipidomics coupled with protein interaction studies could reveal how specific lipid species affect YAP1802 binding
Lipid sensors could map the distribution of different phospholipids in relation to YAP1802 localization
In vitro reconstitution with defined lipid compositions could determine lipid specificity and binding kinetics
Cryo-Electron Tomography:
This technique could visualize endocytic structures with molecular detail
It might capture YAP1802 in action within its native context, revealing structural rearrangements during endocytosis
Optogenetic Approaches:
Light-inducible protein interaction systems attached to YAP1802 could trigger its recruitment or dissociation from membranes on demand
This would allow precise temporal control of YAP1802 function and help establish causality in endocytic events
These advanced techniques would provide unprecedented insights into the molecular mechanisms of YAP1802 function, potentially revealing new therapeutic targets for diseases involving endocytic dysfunction.
Research on YAP1802 has broader implications for understanding human disease mechanisms, particularly those involving endocytosis and membrane trafficking dysregulation:
Neurological Disorders:
The mammalian homologs of YAP1802, AP180 and CALM (Clathrin Assembly Lymphoid Myeloid leukemia protein), have been implicated in several neurological disorders
CALM has been associated with Alzheimer's disease through regulation of amyloid precursor protein endocytosis
Studies of YAP1802's interactions with Snc1/2 provide insights into how synaptic vesicle proteins are recycled in neurons , relevant for understanding synaptic dysfunction in neurodegenerative diseases
Cancer Biology:
The polarized localization mechanisms of YAP1802 dependent on anionic phospholipids may inform our understanding of cell polarity defects in cancer progression
Disruption of endocytic processes is increasingly recognized as a factor in cancer cell behavior, affecting receptor signaling and cell migration
Developmental Disorders:
YAP1802's role in organizing endocytic sites at specific membrane domains parallels processes in mammalian cells where AP180/CALM organizes clathrin-mediated endocytosis at specialized membrane regions
Disruption of these processes is implicated in developmental disorders involving cell polarity and tissue organization
Methodological Insights:
The methodology developed to study YAP1802 point mutations (K21E, K23E, L203S) provides a template for investigating how disease-associated mutations in AP180/CALM might affect protein function
Yeast as a model system allows rapid screening of potential therapeutic approaches targeting AP180/CALM function
The translational potential of YAP1802 research extends beyond basic cell biology, potentially contributing to novel therapeutic strategies for endocytosis-related human diseases through improved understanding of fundamental membrane trafficking mechanisms.
Developing specific and sensitive assays for YAP1802 research presents several methodological challenges:
Antibody Specificity:
Ensuring antibodies can distinguish between the highly similar YAP1801 and YAP1802 proteins
Developing antibodies that recognize specific phosphorylated or modified forms of YAP1802
Creating antibodies that can detect conformational changes in YAP1802 upon binding to lipids or cargo
Functional Redundancy:
Quantitative Imaging:
Developing standardized protocols for measuring YAP1802 recruitment and dynamics across different laboratories
Creating robust image analysis pipelines that can detect subtle differences in localization or dynamics
Establishing appropriate controls and normalization methods for quantitative comparisons
In Vitro Reconstitution:
Purifying functional YAP1802 protein that retains native binding properties
Creating membrane systems that accurately mimic the lipid composition of yeast plasma membrane domains
Developing assays that can simultaneously measure interactions with both lipids and cargo proteins
Temporal Resolution:
Capturing the rapid dynamics of YAP1802 during endocytic events, which may occur on the timescale of seconds
Developing methods to synchronize endocytic events for population-level analysis
Creating experimental designs that can establish causality in rapidly occurring sequential events
Addressing these challenges will require interdisciplinary approaches combining advanced imaging, biochemistry, genetics, and computational analysis, but will ultimately provide more precise and informative assays for understanding YAP1802 function in membrane trafficking.